Latest Autoimmunity Stories
DANVERS, Mass., July 21, 2014 /PRNewswire/ -- The Scleroderma Foundation is preparing for 600 people from around the world to attend its National Patient Education Conference later this week
Annual conference provides groundbreaking approaches to treating patients with interrelated autoimmune conditions. Malvern, PA (PRWEB) July 18, 2014
HERZLIYA, Israel, July 16, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd.
PORTLAND, Ore., July 16, 2014 /PRNewswire-USNewswire/ -- Thirteen scientists received a total of $1.05 million in funding from the National Psoriasis Foundation for projects that aim to identify new
--Novel Biologic Targets Innovative New Mechanism in Lupus-- SEATTLE, July 16, 2014 /PRNewswire/ -- Resolve Therapeutics, LLC announced today the initiation of a multi-dose, one month
SAN DIEGO, July 14, 2014 /PRNewswire/ -- aTyr Pharma, an innovative rare disease therapeutics enterprise announced today, the scientific publication of a splice variant of a tRNA synthetase
New research in Nature Genetics identifies a novel genetic and molecular pathway in the esophagus that causes eosinophillic esophagitis (EoE), opening up potential new therapeutic strategies for an enigmatic and hard-to-treat food allergy.
Researchers have developed an inexpensive and portable new device that uses nanotechnology to diagnose type-1 diabetes – a breakthrough that they claim could improve patient care worldwide and help medical experts better understand the condition.
A number of studies suggest that children delivered by Caesarean section have a different intestinal flora than children delivered by natural birth.
Strengthens Collaboration between the Nation's Lupus Research Organizations NEW YORK, July 8, 2014 /PRNewswire/ -- The Lupus Research Institute (LRI) today announced that Team
- Pertaining to the surface or end opposite to the mouth in a radiate animal.